The $4 Billion Problem in Lyme Diagnostics with Aces Diagnostics
In this episode of Diagnosing Dx, I’m joined by Tammy Crawford, Chief Executive Officer, and Holly Ahern, Chief Scientific Officer at Aces Diagnostics, a company building what could become the first highly accurate test across all stages of Lyme disease.
We explore why early Lyme is so often missed, the myth of the bullseye rash, and the structural gaps in today’s testing pathway. Tammy and Holly explain how their personal experiences shaped Aces Diagnostics’ mission and how they’re approaching the problem with a more rigorous, data-driven framework built for real-world adoption.
This…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.